Prepared by: Jyoti Vyas
Role: Data Analyst | Healthcare Policy Insight Contributor
Date: June 2025
This analysis evaluates the financial and operational dynamics of the U.S. State Drug Utilization Program (SDUP), a Medicaid initiative designed to subsidize healthcare for low-income populations, veterans, and people with disabilities. Using 5.2 million records, we uncover insights into spending efficiency, Medicaid dependence, drug cost patterns, and opportunities for policy optimization.
What is SDUP?
A federal-state initiative under Medicaid, SDUP reimburses prescription drugs provided to Medicaid beneficiaries.
Why Analyze SDUP?
| Metric | Value |
|---|---|
| Total Records | 5.2 million |
| Avg Total Reimbursement | $80,976 |
| Avg Medicaid Reimbursement | $77,945 |
| Avg Package Size | 21 units |
| Avg Units Reimbursed | ~35,000 |
Spending remains steady across all quarters, indicating stable drug utilization trends.